Table of Contents

company-logo

Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. Its products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH samples in real-time; and Allegro Plus, an automatic fluorescent imaging system, which identifies various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. It also offers DUET-3, an imaging and analysis platform that include an automated barcode reader, which enables scanning of various test types in a single scan batch; DeNovo, an automated scanning system for detection, analysis, and characterization of circulating tumor cells from peripheral blood; Solo Workstation, an offline workstation that streamlines and enables review and analysis of test results away from the microscope; Solo Touch Workstation, a stand-alone workstation with advanced review and analysis tools; and SoloWeb, a Web-based solution that provides analysis, reporting, and consulting on BioView-scanned cases. Bio-View Ltd has a partnership agreement with ANGLE plc to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 2000 and is headquartered in Rehovot, Israel.

Bio-View Dividend Announcement

• Bio-View announced a annually dividend of ₪20.00 per ordinary share which will be made payable on 2017-04-06. Ex dividend date: 2017-03-22
• Bio-View's trailing twelve-month (TTM) dividend yield is -%

Bio-View Dividend History

Ex-Div dateDividend amountDividend typePay date
2017-03-22₪20.00annually2017-04-06

Bio-View Dividend per year

Bio-View Dividend Yield

Bio-View current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Bio-View stock? Use our calculator to estimate your expected dividend yield:

Bio-View Financial Ratios

P/E ratio39.95
PEG ratio399.53
P/B ratio1.21
ROE3.14%
Payout ratio0.00%
Current ratio2.89
Quick ratio2.17
Cash Ratio1.16

Bio-View Dividend FAQ

Does Bio-View stock pay dividends?
Bio-View does not currently pay dividends to its shareholders.
Has Bio-View ever paid a dividend?
No, Bio-View has no a history of paying dividends to its shareholders. Bio-View is not known for its dividend payments.
Why doesn't Bio-View pay dividends?
There are several potential reasons why Bio-View would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Bio-View ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Bio-View has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Bio-View a dividend aristocrat?
Bio-View is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Bio-View a dividend king?
Bio-View is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Bio-View a dividend stock?
No, Bio-View is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Bio-View stocks?
To buy Bio-View you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Bio-View stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.